Wednesday, September 9, 2020

Pharma CEOs sign open letter pledging vaccine safety


The NPC Healthbiz Weekly has launched. It's your weekly briefing on topics pertinent to healthcare marketers and executives. From Chronicle Companies, organizers of the 14th National Pharmaceutical Congress, which begins Oct. 21. More info at pharmacongress.info

⇒ Issue #107 (In numerology, 107 enables you to develop motivations and intuitions that will enable you to succeed in life.)
⇒ Confirmed Covid cases in Canada as of 09/09: 135,757*
⇒ Confirmed Covid fatalities in Canada as of 09/09: 9,203*
⇒ Worldwide Covid cases as of 09/09: 27,615,676*
⇒ Worldwide Covid fatalities as of 09/09: 898,426*

September 9, 2020—Welcome to your mid-week reading, and first Daily CurveFlattener of this back-to-school week. It's editorial assistant Jeremy Visser doling out vaccine updates from my desk chair located in the vicinity of Lakeshore and Royal York Roads in Etobicoke, Ont.

In some reassuring updates on the vaccine front, following the U.S. President's head-butting with the FDA (see DCF passim), an open letter has been signed by nine life sciences CEOs pledging to cut no corners with vaccine safety. The CEOs made clear their "on-going commitment to developing and testing potential vaccines for Covid-19 in accordance with high ethical standards and sound scientific principles."



With political pressure on the FDA from the White House, paired with accelerated trials such as CanSino receiving approval for phase III trials in Russia, the open letter comes at a critical time. With a poll showing that 35 per cent of Americans would decline a free FDA-approved vaccine, and 32 per cent of Canadians are hesitant about immediately getting one, the focus of vaccine safety in the open letter seems like a good read of the global attitude on Covid-19 vaccines.

Among one of the companies that signed the open letter, Moderna has reportedly delayed trials on a vaccine in an effort to enroll more at-risk minorities, who have been shown to be disproportionally affected by Covid-19.


COVID CHRONICLE 09/09/2020

  • A recent study published in JAMA Network Open monitored social distancing mandates using anonymous location data from over 45 million mobile phones. The study noted a decrease in travel distances, increase in stay-at-home times, and attributed an association of these findings to a reduced spread of Covid-19.
  • An article published in World Medical & Health Policy looked into the controversial causes of black people being disproportionally affected by Covid-19. Using data from the American Community Survey and Current Population Survey, the authors suggest that the findings could be linked to black people holding more essential worker positions.
  • Scientists at the Okinawa Insitute of Science and Technology Graduate University have developed a low-cost Covid-19 antibody test. The test is done using portable -lab-on-a-chip technology to measure the antibodies present in diluted blood plasma. The process is describe in a study published in Biosensors and Bioelectronics.

WHAT CHRONICLE IS WORKING ON TODAY


I'll be speaking with Dr. Carolyn Jack about her study on using tape strips to identify atopic dermatisis and psoriasis as opposed to skin biopsies. The article will be upcoming in The Chronicle of Skin & Allergy


RIGHT NOW WE ARE LISTENING TO... 


Capstan - Restless Heart, Keep Running. Giving another listen, making this probably #436. They say a good book is like an old friend, so I guess this album must be a close cousin at this point.



TONIGHT WE ARE READING... 


City of Light by Will Wight. Starting off the last book of the Traveler's Gate trilogy. I've been pleasantly surprised at the pacing, world building and plot twists. Quite a debut for a fantasy writer.



HOW IS YOUR WEEK GOING?


Please make use of the comments section at the Daily CurveFlattener, to let us know what you're up to today. Or feel free to check in via LinkedIn, email, or your choice of connector. By all means, pass this newsletter along to your colleagues.



Stay in touch, stay safe and enjoy your day. Editorial Director Allan Ryan will be here tomorrow with your update.

No comments:

Post a Comment

Thanks for posting a comment. Your remarks are waiting for confirmation, which may take a little while. Check back frequently